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The dynamic regulation of ligand binding is considered crucial for integrin function. 
However, the importance of activity regulation for integrin function in vivo is largely 
unknown. Here, we have applied gene targeting to delete the GFFKR sequence of the 
lymphocyte function-associated antigen–1 (LFA-1) 
 
 
 
L
 
 subunit cytoplasmic domain in mouse 
germline. Lymphocytes from 
 
Lfa-1
 
d/d
 
 mutant mice showed constitutive activation of LFA-1–
mediated cell adhesion and impaired de-adhesion from intercellular adhesion molecule-1 
that resulted in defective cell migration. In contrast, signaling through LFA-1 was not 
affected in 
 
Lfa-1
 
d/d
 
 cells. T cell activation by superantigen-loaded and allogeneic APCs, 
cytotoxic T cell activity, T-dependent humoral immune responses, and neutrophil 
recruitment during aseptic peritonitis were impaired in 
 
Lfa-1
 
d/d
 
 mice. Thus, deactivation of 
LFA-1 and disassembly of LFA-1–mediated cell contacts seem to be vital for the generation 
of normal immune responses.
 
Many integrins do not exhibit constitutive
ligand binding capacity, but are expressed in an
inactive state (1, 2). Integrin ligand binding is
activated rapidly and transiently by cytoplasmic
signals initiated by the stimulation of diverse cell
surface receptors (inside-out signaling). The inte-
grin, lymphocyte function-associated antigen-1
(LFA-1; 
 
 
 
L
 
 
 
2
 
), is expressed on all leukocytes
and is considered to play an important role in
host defense (3). LFA-1 shares the 
 
 
 
2
 
 subunit
with Mac-1 (
 
 
 
M
 
 
 
2
 
), p150/95 (
 
 
 
X
 
 
 
2
 
), and 
 
 
 
D
 
 
 
2
 
.
Binding of LFA-1 to its natural ligands, inter-
cellular adhesion molecule (ICAM)-1, ICAM-2,
or ICAM-3, mediates interactions between T
cells and blood vessel endothelium, target cells,
and APCs. LFA-1 stabilizes intercellular adhe-
sion between T cells and APCs, which seems to
be particularly relevant for facilitating T cell ac-
tivation at low antigen concentration (4). In ad-
dition, binding of LFA-1 to its cognate ligands
directly activates the Jnk and Erk-1/2 pathways,
and thereby decreases the threshold of T cell ac-
tivation (5, 6). LFA-1–deficient mice exhibit
reduced lymph node cellularity and splenomeg-
aly  which is consistent with a major role of
LFA-1 in normal lymphocyte recirculation
(7–10). T cells from LFA-1
 
 
 
/
 
 
 
 mice also dis-
played an impaired proliferation in response to
allogeneic cells and mitogen. However, they
mounted normal cytotoxic T cell responses dur-
ing viral infections, but failed to reject immu-
nogenic tumors (7).
The ligand-binding capacity of leukocyte
integrins can be activated by signaling path-
ways emanating from T and B cell antigen re-
ceptors, chemokine receptors, and Toll-like
receptors within a time-scale of seconds to
minutes (1, 11–13). Integrin activation through
these receptors causes large-scale conforma-
tional changes in integrin extracellular domains
that are associated with increased ligand-bind-
ing affinity and leads to receptor clustering at
cell contact areas. The signaling pathways
that control LFA-1 activation are not under-
stood completely, but involve protein kinase
C; phosphatidylinositol 3-kinase; cytohesin-1;
small GTPases; and the adaptor protein,
SLAP-130/Fyb (14–20).
The cytoplasmic domains of 
 
 
 
 and 
 
 
 
 sub-
units are crucial for the regulation of integrin
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ligand-binding activity (1). Thus, changes in the cytoplasmic
tails of integrins affect the structure and function of their ex-
tracellular domains. Mutational analyses have shown that in-
teractions between membrane-proximal sequences of integrin
cytoplasmic domains restrain integrins in an inactive confor-
mation. For example, deletions of the entire 
 
 
 
 subunit cyto-
plasmic domain or of the highly conserved membrane-proxi-
mal GFFKR sequence disrupt interactions of 
 
 
 
 and 
 
 
 
 subunit
tails, and produce constitutively active integrin in vitro. Con-
sistent with this model, the talin head domain activates inte-
grins by binding to the cytoplasmic domain of 
 
 
 
 subunits
and—as a result of the high affinity of this interaction—ablates
interactions between 
 
 
 
 and 
 
 
 
 cytoplasmic domains. Recent
studies that measured fluorescence resonance energy transfer
confirmed these changes of cytoplasmic domain interactions
during integrin activation in living cells in vitro (21).
Although numerous studies have investigated the conse-
quences of integrin deficiencies in mouse models, the in vivo
relevance of restraining LFA-1 in an inactive state on resting
leukocytes and rapidly deactivating LFA-1 after cell stimula-
tion is unknown. In the present study, we mutated the 
 
 
 
L
 
subunit cytoplasmic tail in mouse germline leading to the
expression of constitutively active LFA-1. We show that this
mutation severely impairs immune responses in vitro and in
vivo, and thereby demonstrate that complete deactivation is
essential for the normal function of LFA-1.
Figure 1. Generation of Lfa-1d/d mutant mice. (a) Organization of the 
murine Lfa-1 genomic locus (top), targeting vector (second from top), targeted 
Lfa-1d allele (second from bottom), and Lfa-1d allele following intercross 
with the cre deleter strain (bottom). (b) Southern blot analysis of genomic 
DNA derived from a wild-type mouse (lane 1) and a heterozygous Lfa-1d-neo/  
mouse (lane 2) before deletion of the neocassette using the 3  flanking 
probe. (c) PCR analysis of genotypes from wild-type ( / ), heterozygous 
Lfa-1d/  (d/ ), and homozygous Lfa-1d/d (d/d) mice after deletion of the 
neocassette. To detect the mutant allele, a genomic fragment containing 
the newly introduced HpaI site in exon 31 was amplified by PCR and di-
gested with HpaI. 
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RESULTS
Generation of a mutant mouse strain (
 
Lfa-1
 
d/d
 
) expressing 
constitutively active integrin LFA-1
 
Although the lack of LFA-1–mediated cell adhesion has
been demonstrated to impair immune responses (7), the
functional consequences of defective LFA-1 deactivation are
unknown. To address this question, a mutant mouse strain
(
 
Lfa-1
 
d/d
 
) that exhibits a constitutive germline deletion of the
conserved amino acid motif GFFKR in the membrane-
proximal segment of the LFA-1 
 
 
 
L
 
 chain cytoplasmic do-
main was generated by gene targeting (Fig. 1). This muta-
tion was chosen because deletion of the GFFKR sequence is
known to cause separation of the 
 
 
 
L
 
 and 
 
 
 
2
 
 cytoplasmic tails,
and to result in the constitutive activation of integrins, in-
cluding LFA-1 (21–23). Correct introduction of the GFFKR
deletion was confirmed by cDNA cloning and nucleotide
sequence analysis of 
 
 
 
L
 
 transmembrane and cytoplasmic do-
mains from 
 
Lfa-1
 
d/d
 
 mice (unpublished data). Mutant 
 
Lfa-1
 
d/d
 
mice were born at normal Mendelian ratios, were fertile, and
did not exhibit any gross anatomic or behavioral abnormali-
ties (unpublished data).
To control whether the 
 
Lfa-1
 
d/d
 
 mutation may affect in-
tegrin expression, flow cytometry analyses were performed.
The results in Fig. 2 a show that cell surface expression of
mutant LFA-1 was reduced as compared with the wild-type
integrin. However, analysis of permeabilized cells revealed
that the levels of total cellular LFA-1 protein were not al-
tered by the 
 
Lfa-1
 
d/d
 
 mutation (Fig. 2 a). Moreover, spleno-
cyte mRNA levels for mutant and wild-type LFA-1 did not
differ significantly (unpublished data), and indicated that ex-
pression of the mutant 
 
Lfa-1
 
d
 
 gene was not impaired. In-
stead, these findings are consistent with previous observa-
tions showing that deletion of the membrane-proximal
GFFKR sequence in the LFA-1 
 
 
 
L
 
 subunit affects surface
expression by reducing heterodimer formation with the 
 
 
 
2
subunit (23). Additional flow cytometry analyses of B and T
cells and neutrophils demonstrated that the integrins, 
 
 
 
X
 
 
 
2
 
and Mac-1, which share the 
 
 
 
2
 
 subunit with LFA-1, were
expressed at similar levels on 
 
Lfa-1
 
d/d
 
 and wild-type cells
(Fig. 2 b). Moreover, 
 
Lfa-1
 
d/d
 
 and wild-type cells also did
not differ in their expression of unrelated 
 
 
 
4
 
 
 
1
 
 and 
 
 
 
2
 
 
 
1
 
 in-
tegrins (Fig. 2 b); this indicates that the 
 
Lfa-1
 
d/d
 
 mutation
does not alter the global expression of leukocyte integrins.
The effect of the 
 
Lfa-1
 
d/d
 
 mutation on cell adhesion was
investigated using a recombinant ICAM-1(D1-2)-Fc pro-
tein. The results in Fig. 3 a demonstrate that adhesion of un-
stimulated 
 
Lfa-1
 
d/d
 
 thymocytes to ICAM-1(D1-2)-Fc was
significantly elevated as compared with cells that expressed
wild-type LFA-1. Exposure to the integrin activator, Mn
 
2
 
 
 
,
or incubation with phorbol ester further increased binding of
 
Lfa-1
 
d/d
 
 and wild-type thymocytes to ICAM-1(D1-2)-Fc.
However, even under these conditions, 
 
Lfa-1
 
d/d
 
 cells
adhered more strongly to ICAM-1(D1-2)-Fc than did wild-
type cells. Notably, ICAM-1(D1-2)-Fc adhesion of unstim-
ulated 
 
Lfa-1
 
d/d
 
 cells was similar to that of Mn
 
2
 
 
 
- or PMA-
stimulated wild-type cells (Fig. 3 a). Maximal adhesion of
wild-type thymocytes required stimulation with Mn
 
2
 
 
 
 and
PMA, whereas for 
 
Lfa-1
 
d/d
 
 cells, incubation with a single
stimulus was sufficient. The absolute levels of maximal adhe-
sion to ICAM-1(D1-2)-Fc did not differ between 
 
Lfa-1
 
d/d
Figure 2. Integrin expression in Lfa-1d/d mice. (a) Cell surface levels of 
LFA-1 and total cellular LFA-1 protein were measured by flow cytometry 
analyses of Lfa-1d/d (red lines) and wild-type (blue lines) splenocytes. 
(b) Cell surface integrin expression was determined on Lfa-1d/d (red lines) 
and wild-type (blue lines) splenic T cells (CD3  cells), B cells (B220  cells), 
and bone marrow neutrophils (Gr-1  cells). Staining with isotype-matched 
controls is indicated as dotted lines (n   3 independent experiments). 
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and wild-type cells (Fig. 3 a). To control whether the
GFFKR deletion in the mouse 
 
 
 
L
 
 gene specifically affects
the integrin, LFA-1, thymocyte adhesion to vascular cell ad-
hesion molecule (VCAM)-1-Fc, which interacts with  4 1
and  4 7 integrins, was examined. As depicted in Fig. 3 b,
binding of Lfa-1d/d and wild-type thymocytes to VCAM-1-Fc
was comparable for all conditions tested. These results dem-
onstrate that the Lfa-1d/d mutation results in a constitutive,
but partial, activation of LFA-1. Moreover, the maximal
LFA-1–mediated adhesive capacity of cells was not altered
by this mutation, and suggests that cell surface expression of
mutant LFA-1 is sufficient for its functionality. Consistent
with this notion, previous work showed that only a small
subset of the integrin, Mac-1 ( M 2), is sufficient to mediate
the full adhesive capacity of neutrophils (24).
In contrast to stimulation with PMA, activation of inte-
grin ligand-binding by the T cell antigen receptor and che-
mokines is mediated by Rap1, together with other signaling
molecules (14, 25, 26). The critical cytoplasmic region of  L
that is required for Rap1 responsiveness is adjacent to the
GFFKR sequence (27); this raises the possibility that dele-
tion of the GFFKR sequence in Lfa-1d/d mice would alter
activation of LFA-1 through the T cell receptor. Therefore,
we investigated LFA-1 activation in response to T cell re-
ceptor signaling. Lymph node cells from wild-type and Lfa-
1d/d mice that were stimulated with PMA and ionomycin,
and maintained in IL-2, were stimulated with CD3 antibod-
ies and adhesion to ICAM-1(D1-2)-Fc was measured. The
results in Fig. 3 c show that CD3 treatment induced adhe-
sion of wild-type and Lfa-1d/d cells to a similar extent; the
adhesion of Lfa-1d/d cells was accelerated slightly 10 min after
addition of CD3 antibodies. Therefore, these data indicate
that the  L-GFFKR deletion did not impair activation of
LFA-1 in response to T cell receptor ligation.
LFA-1 is crucial for the firm adhesion of leukocytes to
endothelial cells and the subsequent process of transendothe-
lial migration. Therefore, we investigated the effects of the
Lfa-1d/d mutation on leukocyte endothelial interactions. Fig.
3 d shows that binding of resting splenocytes and lymph
node cells to unstimulated bEnd5 endothelioma cells was not
influenced by the Lfa-1d/d mutation. However, when bEnd5
cells were stimulated with TNF to up-regulate ICAM-1,
binding of Lfa-1d/d splenocytes and lymph node cells was in-
creased significantly as compared with wild-type cells. In
marked contrast to cell adhesion, Lfa-1d/d lymphocytes that
were derived from spleen or lymph nodes were impaired
significantly in their capacity to transmigrate bEnd5 endo-
thelial cell monolayers (Fig. 3 e).
Impaired de-adhesion and migration of lymphocytes 
expressing mutant LFA-1
To investigate further why the  L-GFFKR deletion con-
ferred enhanced ability of T cells to adhere to ICAM-1, but
retarded their ability to migrate across stimulated endothe-
Figure 3. Lfa-1d/d mutation enhances cell adhesion but impairs en-
dothelial transmigration. Thymocytes were incubated with plates coated 
with purified ICAM-1(D1-2)-Fc (a) or VCAM-1-Fc (b) and the fraction of 
adherent cells was determined (n   4–8 independent experiments). 
(c) Lymph node cells stimulated with PMA and ionomycin and rested in 
IL-2 were incubated with CD3 mAbs for the indicated periods (10 and 40 
min) and adhesion to ICAM-1(D1-2)-Fc was determined. Results are 
presented as percentage increase of ICAM-1(D1-2)-Fc adhesion of CD3-
stimulated as compared with unstimulated cells. (d) Splenocytes (SPL) or 
lymph node (LN) cells were plated on bEnd5 endothelioma cells that were 
unstimulated (medium) or treated with TNF for 16 h. The number of cells 
adherent per unit area were determined (n   5 independent experiments). 
(e) Transmigration of unstimulated (medium) or TNF-treated bEnd5 
endothelioma cells by splenocytes or lymph node cells (right panel) 
was measured (n   6 independent experiments). *P   0.05; #P   0.01 
(Student’s t test).JEM VOL. 201, June 20, 2005 1991
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lium, we turned to videomicroscopy to investigate directly
the effects of the LFA-1 mutation on T cell migration on
immobilized ICAM-1-Fc. T cells used in these experiments
were stimulated with ConA and rested in IL-2 before exam-
ining their migratory capacity. The results show that the av-
erage migratory speed of Lfa-1d/d T cells was reduced se-
verely to  20% of the speed of wild-type T cells, whereas
ICAM-1-Fc adhesion of Lfa-1d/d T cells was increased
slightly as compared with wild-type cells (Fig. 4, a and b).
Tracking of individual T cells revealed that the distance mi-
grated by each individual T cell was reduced greatly by the
 L-GFFKR mutation (Fig. 4 c and d). Time-lapse videomi-
croscopy analysis of migrating T cells demonstrated that Lfa-
1d/d T cells were unable to translocate because they were at-
tached firmly at their trailing edges (Videos 1 and 2, available
at http://www.jem.org/cgi/content/full/jem.20041850/
DC1). Therefore, these results indicate that the  L-GFFKR
mutation results in impaired de-adhesion at trailing edges of
migrating cells, and, consequently, inefficient cell transloca-
tion. Thus, complete deactivation of the integrin, LFA-1,
may be required to mediate sequential adhesion and de-
adhesion events during cell migration.
Influence of the Lfa-1d/d mutation on lymphoid 
organogenesis and lymphocyte development
LFA-1 deficiency was found to alter the cellularity of pe-
ripheral lymphoid organs (7, 9). Therefore, we investigated
the influence of constitutive LFA-1 activation on lymphoid
organogenesis. Analysis of different lymphoid organs re-
vealed that total cell numbers in peripheral lymph nodes and
Peyer’s patches were reduced substantially in Lfa-1d/d mutant
mice when compared with wild-type littermates (Table I).
In contrast, spleen cell numbers were significantly greater in
Lfa-1d/d mice than in wild-type mice. Bone marrow and
thymus cellularity as well as peripheral blood leukocyte
numbers were not altered by the Lfa-1d/d mutation. This
phenotype of Lfa-1d/d mice is similar that of Lfa-1 /  mice,
and suggests that the presence and the full conformational
flexibility of LFA-1 are required for the normal development
of secondary lymphoid organs.
Based on these results, we next examined the effects of
the Lfa-1d/d mutation on B and T cell development. The
results showed that ratios of major B and T lymphocyte
subsets in bone marrow (B220loIgM , B220loIgM , and
B220hiIgMhi cells), thymus (CD4 and CD8 double negative,
double positive, and single positive cells), spleen (IgMhiIgDlo
and IgMloIgDhi cells), and lymph nodes (CD4 CD8  and
CD8 CD4  cells) were not affected in Lfa-1d/d mice (un-
published data). To investigate T cell development further,
the T cell receptor V  repertoire was determined in thy-
mocytes. The results demonstrated that the V  repertoire
did not differ significantly between Lfa-1d/d mutant and
wild-type mice (unpublished data). Thus, constitutive acti-
vation of LFA-1 alters the cellularity of secondary lymphoid
organs, but does not seem to have a major influence on B
and T cell development.
Lfa-1d/d mutation impairs activation of T cells through APCs
LFA-1 on T cells mediates contacts with APCs, and thereby,
decreases the amount of antigen that is required for T cell ac-
tivation (4). To investigate the influence of the Lfa-1d/d gain-
Figure 4. T cell adhesion and migration on immobilized ICAM-1-Fc. 
(a) Adhesion of spleen T cells onto immobilized ICAM-1 in the presence of 
6 mM Mg2  was determined after 30 min (mean   SD). (b) T cells migrating 
on 50  g/ml immobilized ICAM-1-Fc with calculation of speed over 10 min. 
The speed of Lfa-1d/d T cells is expressed as percentage of wt T cell speed   
SEM (***P   0.01). (c) Phase images of migrating T cells. The red circle
indicates the position of the T cell at 0 s; the yellow line details the T cell 
trajectory over 180 s. White bars, 10  m. (d) Migration of T cells was 
tracked over 600 s; each line represents one T cell (wt, n  20; Lfa-1d/d, 
n   21). Experiments are representative of n  2 (a) and n   6 (b–d).
Table I. Lymphoid organ development in Lfa-1d/d mice
Cell numbers ( 106)
Organ Wild type Lfa-1d/d p-value
Thymusa 70.4   4.8 61.8   4.3 NS
Bone marrowb 35.0   7.3 29.0   4.1 NS
Spleena 71.9   7.0 95.1   8.4 0.040
Lymph nodesa 1.31   0.10 0.54   0.09  0.0001
Peyer’s patchesa 0.39   0.04 0.11   0.02  0.0001
Bloodc 2.2   0.5 2.7   0.4 NS
Data are derived from at least six independent mice per group.
aCells/organ.
bCells/femur.
cCells/ml.LFA-1 DEACTIVATION CONTROLS IMMUNE RESPONSES | Semmrich et al. 1992
of-function mutation on T cell responses directly, we stimu-
lated splenocyte cultures by incubation with the bacterial
superantigen, Staphylococcal enterotoxin B (SEB), which ac-
tivates V 8  T cells of CD4 and CD8 subsets. The dose–
response curve depicted in Fig. 5 a demonstrates that prolif-
eration of Lfa-1d/d T cells was attenuated significantly as
compared with wild-type cells at all concentrations of SEB
tested. Moreover, in allogeneic mixed lymphocyte reactions
with irradiated BALB/c splenic stimulator cells, the prolifera-
tion of Lfa-1d/d T cells was reduced significantly as compared
with wild-type T cells (Fig. 5 b). To analyze further the ef-
fects of the Lfa-1d/d mutation on T cell activation, the induc-
tion of CD25 and CD69 expression on SEB-stimulated T
cells was studied. The results in Fig. 5 c demonstrate signifi-
cantly reduced expression of CD25 and CD69 on Lfa-1d/d as
compared with wild-type T cells. Together, these results in-
dicate that T cell activation by superantigen-pulsed or alloge-
neic APCs is impaired markedly by the Lfa-1d/d mutation.
To distinguish whether reduced activation of Lfa-1d/d T
cells may result from altered interactions with APCs or from
T cell intrinsic defects, purified splenic T cells were stimu-
lated with a range of concentrations of plate-bound CD3 an-
tibody. The results in Fig. 5 d clearly show that Lfa-1d/d T
cells proliferate as efficiently as do wild-type T cells in re-
sponse to plate-bound CD3, which suggests that the Lfa-1d/d
mutation does not cause a general defect of T cells to re-
spond to antigen receptor–mediated stimulation.
In additional experiments, potential mechanisms under-
lying impaired activation of Lfa-1d/d T cells were investi-
gated. Expression of activated LFA-1 may improve and
extend stable contact formation, which may lead to hyper-
activation of T cells and accelerated apoptosis. To address
this question directly, T cells were stimulated with SEB for
various periods and the fraction of apoptotic V 8  T cells
was determined by annexin V staining. The results depicted
in Fig. 6 a show that under the experimental conditions that
were used, activation-induced cell death did not occur in
wild-type or Lfa-1d/d T cells. Instead, when compared with
unstimulated V 8  T cells, stimulation with SEB reduced
the fraction of apoptotic wild-type and Lfa-1d/d T cells to a
similar extent (Fig. 6 a). To investigate further the influence
of the Lfa-1d/d mutation on T cell apoptosis after antigen re-
ceptor engagement, SEB was injected into hind footpads of
mice. The results in Fig. 6 b show that deletion of V 8  T
cells caused by in vivo SEB administration was similar in
wild-type and Lfa-1d/d mice. Thus, the  L-GFFKR deletion
of LFA-1 does not seem to lead to increased T cell apoptosis
after antigen receptor stimulation.
Figure 5. Lfa-1d/d mutation impairs T cell proliferation stimulated 
by APCs. Splenocytes from wild-type or Lfa-1d/d mice were stimulated 
with the indicated concentrations of SEB (a) or irradiated BALB/c spleno-
cytes or autologous cells (b). 3[H]-thymidine incorporation was measured 
72 h later (n   6 independent experiments). (c) Splenocytes were incu-
bated with SEB (10  g/ml) for 16 h. The percentage of CD4 T cells from 
wild-type and Lfa-1d/d mice expressing CD25 and CD69 was determined by 
flow cytometry (n   4–5 independent experiments). (d) Enriched splenic T 
cells were stimulated with plate-bound CD3 antibody, and 3[H]-thymidine 
incorporation was measured after 72 h (n   4 independent experiments). 
*P   0.05; #P   0.01 (Student’s t test).JEM VOL. 201, June 20, 2005 1993
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Lfa-1d/d mutation does not influence signaling through LFA-1
Integrins may function as signaling receptors, and integrin li-
gation may trigger signaling processes that influence cellular
activation and proliferation (1). Therefore, we addressed the
question of whether partial activation of LFA-1 through the
Lfa-1d/d mutation may result in constitutive signaling activity
or enhanced ligand-induced signaling. LFA-1 ligation was
shown previously to induce activation of JNK and Erk1/2
MAP kinases (5). As shown in Fig. 6 c, constitutive levels of
phosphorylated JNK or Erk1/2 did not differ between Lfa-
1d/d and wild-type cells. Exposure of cells to recombinant
ICAM-1(D1-2)-Fc induced robust phosphorylation of JNK,
which was not influenced by the expression of activated
LFA-1d. In addition, Lfa-1d/d and wild-type cells exhibited
low, but comparable, levels of Erk1/2 phosphorylation fol-
lowing incubation with ICAM-1(D1-2)-Fc. Enforced ex-
pression of constitutively active Rap1, which functions as a
potent integrin activator, impaired T cell activation by ele-
vating cellular levels of the cyclin-dependent kinase inhibi-
tor, p27Kip1 (28). In addition, LFA-1 may influence cellular
p27Kip1 levels by its capacity to signal through JAB1 (5, 6),
which is involved in the control of p27Kip1 degradation (29).
Therefore, we compared p27Kip1 protein levels in nuclear
extracts of Lfa-1d/d and wild-type thymocytes. However, the
results in Fig. 6 d demonstrate that the Lfa-1d/d mutation did
not alter p27Kip1 levels. Thus, constitutive or ligand-induced
signaling through LFA-1 does not seem to be influenced by
the Lfa-1d/d mutation.
Lfa-1d/d mutation reduces lytic activity but not generation 
of cytotoxic T lymphocytes
To investigate the effects of the Lfa-1d/d mutation on T cell
functions in more detail, mice were immunized with oval-
bumin and CpG-DNA as adjuvant and cytotoxic T cell ac-
tivity was determined in vitro. These conditions of immuni-
zation result in a strong activation of APCs and render the
generation of antigen-specific cytotoxic cells independent of
CD4 T cells (30, 31). The results in Fig. 7 a show that the
lytic activity of Lfa-1d/d cells against EL4 target cells pulsed
with the ovalbumin-derived peptide, SIINFEKL, was re-
duced greatly when compared with wild-type controls.
These results may be due to an impaired generation of cyto-
Figure 6. Lfa-1d/d mutation does not alter T cell apoptosis and 
LFA-1–mediated signaling. (a) Splenocytes from wild-type or Lfa-1d/d 
mice were stimulated with SEB (10  g/ml) and the percentage of V 8  T 
cells that stained positive for annexin V was determined by flow cytometry 
(n   4 independent experiments). (b) The fraction of V 8  CD4 and CD8 T 
cells was determined in popliteal lymph nodes of mice left untreated (Ctrl) 
and 24 h after s.c. injection of 10  g SEB into each hind footpad. n   4 
mice per group; #P   0.01, *P   0.05 (ctrl vs. SEB). (c) Lymph node cells 
from Lfa-1d/d (d/d) and wild-type mice ( / ) were unstimulated or incu-
bated with 10  g/ml purified soluble ICAM-1(D1-2)-Fc for 30 min in the 
presence of 1 mM Mn2 . Phosphorylation and total protein levels of Jnk 
and Erk-1/2 were determined by Western blot analyses of cell lysates. 
(d) Nuclear extracts were prepared from thymocytes of Lfa-1d/d (d/d) and 
wild-type mice ( / ), and protein levels of p27Kip1 and laminA/C were 
determined by Western blot analysis.LFA-1 DEACTIVATION CONTROLS IMMUNE RESPONSES | Semmrich et al. 1994
toxic T cells in Lfa-1d/d mutant mice or a reduced capacity of
these cells to kill target cells. To distinguish between these
possibilities, antigen-specific CD8 T cells were quantitated
with SIINFEKL-loaded H-2Kb tetramers after immunization
of mice with ovalbumin and CpG-DNA. As depicted in Fig.
7 b, the proportion of tetramer-binding CD62lo CD8 T cells
was greater in Lfa-1d/d mice than in wild-type mice (0.81  
0.13% for Lfa-1d/d mice versus 0.34   0.08% for wild-type
mice; n   6; P   0.01), whereas comparable tetramer stain-
ing was observed in the CD62hi subset of CD8 T cells
(0.36   0.08% for Lfa-1d/d mice versus 0.53   0.11% for
wild-type mice; n   6; P   0.394). These results suggest
that the Lfa-1d/d mutation impairs the lytic activity, but not
the generation, of CD8 T cells.
Impaired humoral immune response in Lfa-1d/d mice
The Lfa-1d/d mutation was found to perturb cell contact–
dependent responses of immune cells in vitro. To investigate
further the effects of the Lfa-1d/d mutation on immune re-
sponses in vivo, the development of T cell–dependent hu-
moral immunity was studied. Mice were immunized with
TNP-CGG adsorbed to alum as an adjuvant; TNP-specific
antibody production was measured 21 d later. The results in
Fig. 8 demonstrate that the production of TNP-specific IgM
as well as IgG1 and IgG2a antibodies were impaired in Lfa-
1d/d mice; this suggests that T helper 1- and T helper 2-type
responses were affected. Therefore, these results indicate that
T cell–dependent humoral immune responses are attenuated
substantially in Lfa-1d/d mutant mice.
Delayed recruitment of Lfa-1d/d neutrophils in inflammation
LFA-1 is crucial for the recruitment of leukocytes from the
blood circulation to inflamed tissues. In vitro experiments
have shown that the Lfa-1d/d mutation enhances adhesion to
endothelial cells, but impairs transendothelial migration and
cell motility on ICAM-1-Fc (Figs. 3 and 4). To elucidate the
relevance of the Lfa-1d/d mutation for inflammatory re-
sponses in vivo, aseptic peritonitis was induced by
thioglycollate injection, and the recruitment of neutrophils
(Gr-1hiMac-1hi cells) was monitored. In wild-type mice, i.p.
injection of thioglycollate caused a marked and rapid influx
of neutrophils (Fig. 9). Peritoneal neutrophil numbers were
highest after 6 h and declined thereafter. However, in Lfa-
1d/d mutant mice, neutrophil accumulation was delayed sub-
stantially. Thus, neutrophil numbers were reduced by  60%
in Lfa-1d/d mice as compared with wild-type mice when an-
Figure 7. Distinct effects of the Lfa-1d/d mutation on the lytic 
activity and generation of cytotoxic T cells. (a) Lfa-1d/d and wild-type 
mice were immunized with OVA using CpG-DNA as adjuvant. Draining 
lymph node cells were harvested 4 d later and cultured with rIL-2 for an 
additional 4 d. CTL activity was assayed using untreated (dotted lines) or 
SIINFEKL-pulsed (solid lines) EL4 cells (n   3–4 independent experiments). 
(b) Lfa-1d/d (d/d) and wild-type mice (wt) were immunized with OVA and 
CpG-DNA. Draining lymph nodes were harvested 9 d later and CD8 T cells 
were analyzed for SIINFEKL/H-2Kb tetramer and CD62L antibody staining 
(n   6 independent mice per group). *P   0.05; #P   0.01 (Student’s t test).
Figure 8. Impaired T cell–dependent antibody responses in Lfa-1d/d 
mice. T cell-dependent production of TNP-specific antibody isotypes was 
measured in serum of wild-type (diamonds) and Lfa-1d/d mice (circles) 
after immunization of mice with TNP-CGG adsorbed to alum (n   7–9 
independent mice per group). *P   0.05; #P   0.01 (Student’s t test).
Figure 9. Delayed neutrophil recruitment during peritonitis in Lfa-1d/d 
mice. Lfa-1d/d and wild-type mice were injected i.p. with thioglycollate 
and infiltrating neutrophils were identified by their Gr-1hiMac-1hi-staining 
profile in flow cytometry analysis n   4–6 independent mice per group. 
*P   0.05 (Student’s t test).JEM VOL. 201, June 20, 2005 1995
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alyzed 6 h after thioglycollate injection (Fig. 9). At the 12-h
time point, comparable numbers of Lfa-1d/d and wild-type
neutrophils were observed in inflamed peritoneal cavities.
Therefore, these results show that the Lfa-1d/d mutation sub-
stantially impairs inflammatory cell recruitment.
DISCUSSION
It is well-established that many integrins are preformed as
inactive cell surface receptors that are responsive to diverse
cellular signals, and result in rapid activation of ligand-bind-
ing capacity followed by deactivation of integrins to a rest-
ing state (1, 32). Although numerous studies have investi-
gated the molecular mechanisms of integrin activation in
vitro, the relevance of dynamic activity regulation for inte-
grin function in vivo remains largely unknown. In the
present study, we have addressed this question by the gener-
ation and analysis of a mouse strain exhibiting a constitutive
germline deletion of the conserved GFFKR sequence in the
LFA-1  L subunit. The consequences of this mutation for
the LFA-1–mediated adhesion of normal mouse cells were
consistent with in vitro studies using cell transfectants (23).
Cells from Lfa-1d/d mutant mice exhibited an increased con-
stitutive adhesion to purified LFA-1 ligand and endothelial
cells and were more responsive to integrin-activating stim-
uli. However, the maximal adhesive capacity of lympho-
cytes to ICAM-1 was not influenced by the Lfa-1d/d muta-
tion. Importantly, videomicroscopy analyses demonstrated a
defective detachment of the trailing edge of Lfa-1d/d cells
migrating on an ICAM-1-Fc–coated surface, and thereby
indicates that the Lfa-1d/d mutation impairs de-adhesion of
cells from LFA-1 ligands. Consistent with these results, it
was shown previously that stabilizing the active form of
LFA-1 with mAb24 causes impaired de-adhesion of T cells
from ICAM-1 (33). In contrast to the effects on cell adhe-
sion, constitutive or ligand-induced signaling of LFA-1 was
not altered in Lfa-1d/d cells. Therefore, these results demon-
strate that the Lfa-1d/d mutation resulted in a constitutive,
but partial, activation of LFA-1–mediated cell adhesion that
was associated with defective disassembly of LFA-1–medi-
ated cell adhesions.
Lack of LFA-1–mediated cellular interactions in  L-defi-
cient mice was shown to cause multiple immune defects (7).
Thus,  Lfa-1–/– mice showed splenomegaly and reduced
lymph node sizes, impaired proliferative response of T cells
to allogeneic stimulators, attenuated thioglycollate-induced
peritonitis, and reduced NK cell cytotoxicity and delayed-
type hypersensitivity responses. Therefore, it was conceiv-
able that enhancing interactions of immune cells through
constitutive activation of LFA-1 may cause hyperinflamma-
tory responses. However, analysis of Lfa-1d/d mice revealed
opposite results, and demonstrated that the Lfa-1d/d mutation
also impaired immune responses. Similar to the phenotype
of Lfa-1–/– mice, we found Lfa-1d/d mice to exhibit enlarged
spleens and hypoplastic lymph nodes, to show impaired
mixed lymphocyte responses, and to have a reduced recruit-
ment of neutrophils to the inflamed peritoneal cavity. In ad-
dition, T cell activation by superantigen-loaded APCs, cyto-
toxic T cell activity, and T cell-dependent humoral immune
responses were impaired markedly by the Lfa-1d/d mutation.
Therefore, these results suggest that the capacity to deacti-
vate LFA-1 fully may be as important for the generation of
normal immune responses as the presence of LFA-1 and the
ability to activate its functions.
Cell contacts mediated by LFA-1 are transient; perturb-
ing the kinetics or duration of these cellular interactions may
impair recruitment or responses of immune cells (11). The
orderly regulation of cell adhesion and de-adhesion is partic-
ularly relevant for cell migration (3, 34). Formation of adhe-
sion sites at the leading edge of the cell is required to provide
traction sites, whereas cell adhesions have to be disassembled
at the rear of the cell to allow it to detach and move forward.
Thus, the lack of integrin activation and the inability to de-
activate integrins are expected to impair cell migration. In
vitro studies using activating antibodies (33) or transfectants
expressing LFA-1 mutants (35) have confirmed this hypoth-
esis for lymphoid cells. The results of the present report ex-
tend this concept to normal leukocytes and in vivo condi-
tions. We show that lymphocytes from Lfa-1d/d mice are
impaired severely in their capacity to migrate on ICAM-
1-Fc and to translocate through endothelial monolayers in
vitro, whereas in vivo, the recruitment of Lfa-1d/d neutro-
phils in a model of aseptic peritonitis was delayed strongly.
In addition, the reduced migratory capacity of lymphocytes
may contribute to alterations of secondary lymphoid organ
cellularity in Lfa-1d/d mice. It is conceivable that the hypo-
plasia of lymph nodes and Peyer’s patches in Lfa-1d/d mice
results from the partial inability of lymphocytes to cross high
endothelial venules, and that cells that are unable to enter
these organs accumulate in spleen.
Immune responses involving cell contact–dependent ac-
tivation and effector function of T cells were impaired mark-
edly by the Lfa-1d/d mutation. Thus, T cell proliferation in
response to superantigen-loaded and allogeneic APCs, as
well as cytotoxic T cell activity, were reduced. These find-
ings are consistent with previous work that showed that sta-
bilizing the active form of LFA-1 by mAb24 inhibited the
proliferative response of T cells to antigen and the cytolytic
activity of lymphokine-activated killer cells (33). Because the
Lfa-1d/d mutation and mAb24 treatment disable complete
deactivation of LFA-1, impaired resolution of LFA-1–medi-
ated cell adhesions may be a major mechanism that underlies
these defective responses. For example, cytotoxic T cells ex-
ert their full cytolytic activity by successive interactions with
multiple target cells. Therefore, defective de-adhesion of cy-
totoxic T cells from target cells would reduce the number of
target cells encountered and killed. Furthermore, the process
of T cell activation by APCs involves successive phases of
transient and long-term cellular contacts, followed by the
detachment of T cells before they undergo cell division and
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de-adhesion of Lfa-1d/d T cells may reduce cell proliferation
and the subsequent formation of new cell contacts by anti-
gen-activated T cells.
In contrast to the capacity of cytotoxic T cells to lyse tar-
get cells, generation of antigen-specific CD8 T cells was not
impaired in Lfa-1d/d mice using an immunization protocol
that renders cytotoxic T cell induction independent of CD4
T cell help (30, 31). A possible explanation for this result
may be provided by studies with  L-deficient mice which
showed that LFA-1 is not required for the generation of cy-
totoxic T cells (7). Alternatively, or in addition, CD8 T cells
may not be sensitive to delayed de-adhesion from APCs, or
activation of APCs by a strong Toll-like receptor agonist,
such as CpG-DNA, may dampen the influence of LFA-1
through induction of additional cell adhesion receptors and
costimulatory molecules. Moreover, T cells that are acti-
vated in local lymph nodes are known to resume their mi-
gratory behavior and continue to recirculate after a short sta-
tionary period. Therefore, it also is possible that the defect of
Lfa-1d/d T cells in cell migration impairs the exit of activated
Lfa-1d/d T cells and, as opposed to wild-type T cells, results
in their prolonged accumulation in lymph nodes.
T helper cell–dependent humoral immune responses
were impaired substantially in Lfa-1d/d mice. Generation of
T-dependent antibody responses involves movement of an-
tigen-specific B cells to the edges of B cell follicles where
they present antigen to specific CD4 T cells that have mi-
grated to this site after activation by, and detachment from,
dendritic cells (39). Activated B cells expand and remain in
the follicles to become germinal center cells, or differentiate
into plasma cells that migrate to the lymph node medulla and
other sites (39, 40). Defective resolution of cell adhesions
also may contribute, at least in part, to the reduced T-depen-
dent antibody production in Lfa-1d/d mice. This mechanism
may attenuate activation and proliferation of antigen-specific
T cells, but also may retain these cells in the T cell area, and
thereby, prevent interaction with specific B cells. Efficient
movement of T and B cells between different anatomic
compartments of lymphoid organs may be impaired further
by the reduced migratory capacity of Lfa-1d/d cells.
To elucidate further the mechanisms underlying im-
paired immune responses of Lfa-1d/d cells and mice, we in-
vestigated whether the Lfa-1d/d mutation may cause in-
creased apoptosis as a result of hyperactivation of T cells, or
alter LFA-1–mediated signaling. However, T cell apoptosis
following in vitro SEB stimulation or in vivo administration
of SEB did not differ between wild-type and Lfa-1d/d T cells.
In addition, neither the constitutive nor the ICAM-1–induced
activation of Jnk and Erk-1/2 MAP kinases was augmented
in Lfa-1d/d cells. Finally, the cyclin-dependent kinase inhibi-
tor, p27Kip1, that was shown to be up-regulated by overex-
pression of the integrin activator, Rap1 (28), and may be tar-
geted by LFA-1 signaling through JAB1 (29), was expressed
at normal levels in Lfa-1d/d cells. Activation of purified T
cells by plate-bound CD3 antibody also was normal, and
thereby confirmed that Lfa-1d/d T cells do not exhibit an in-
trinsic defect to be activated through the antigen receptor.
In summary, we have generated a mutant mouse strain
that shows expression of constitutively active integrin LFA-1,
and thereby disables complete deactivation of LFA-1. The
results demonstrate that deactivation of LFA-1 and resolu-
tion of LFA-1–mediated cell adhesion are vital for the gen-
eration of normal immune responses in vitro and in vivo.
Therefore, the present study supports the concept that dy-
namic regulation of ligand-binding capacity is a key element
of integrin function.
MATERIALS AND METHODS
Antibodies and reagents. Antibodies against the surface markers CD3 
(145-2C11), CD4 (GK1.5), CD8 (53–6.7), CD11a (2D7), CD11b (M1/
70), CD11c (HL3), CD18 (C61/17), CD25 (3C7), CD29 (HM 1-1),
CD49b (Ha1/29), CD49d (R1-2), CD62 (MEL-14), CD69 (H1.2F3),
B220 (RA3-6B2), Gr1 (RB6-8C5), T cell receptor V 8 (F23.1), and an-
nexin V were from BD Biosciences. Antibodies against p27Kip1, laminA/C,
(p)ERK, and (p)JNK were from Cell Signaling. Thioglycollate was from
Difco Labs and SEB was from Toxin Technology. TNP-CGG and TNP-
BSA were from Biosearch Technologies, and alum was obtained from
Serva. ConA, PMA, and ionomycin were purchased from Sigma-Aldrich.
Gene targeting and mice. A murine genomic ES-129 BAC library (Ge-
nome Systems, Inc.) was screened by hybridization with a 225-bp murine
Lfa-1 cDNA fragment encompassing exon 31 as a probe. BAC fragments
were cloned into pBluescript (Stratagene) and fully sequenced. The target-
ing vector was constructed in pBluescript such that the specific mutation
and an additional HpaI-cut were introduced into the short arm. The long
arm was flanked by a neomycin resistance cassette and a HSV–thymidine
kinase cassette. E14.1 embryonic stem cells were electroporated with the
ClaI-linearized targeting vector, and the transfected cells were subjected to
G418 and gancyclovir selection. Homologous recombinated clones were
detected by genomic PCR and confirmed by Southern blot hybridization
after digestion of embryonic stem cell DNA with HpaI. Single integration
was verified by probing the Southern blot with the neomycin resistance cas-
sette. Germline transmission of the targeted allele was confirmed by South-
ern blot analysis and the neogene was removed from germline by crossing
mutant mice with the cre deleter strain (41).
The mice used in these experiments were homozygous for the muta-
tion and had lost the neocassette. Wild-type littermates were used as
controls. Genotyping for the lfa-1d/d mutation was performed by PCR
(forward: 5 -AGCCCTGGCTATCCTAGACTC-3 ; reverse: 5 -GGTC-
CTGAGATGGCAGTTTCTCCG-3 ) followed by HpaI digestion of the
PCR product. Mice were kept according to national guidelines for animal
care in a specific pathogen-free animal facility. Animal studies were ap-
proved by the Regierung von Oberbayern.
Adhesion assays. ICAM-1(D1-2)-Fc and VCAM-1-Fc fusion proteins
containing the human Fc 1 fragment were purified from supernatants of
transfected 293T using protein A–sepharose columns. For cell adhesion as-
say, 96-well plates were coated with 1.5  g/well purified ICAM-1(D1-2)-
Fc, VCAM-1-Fc (0.8  g/well), or Fc 1 fragments (1.0  g/well) overnight
at 4 C. The plates were washed with HBSS and blocked with 1% BSA for 1 h
at 37 C. Cells were labeled for 30 min at 37 C with 6  g/ml H33342 dye
(Calbiochem) in HBSS and washed twice with HBSS. The cells (2   106
cells/ml) were resuspended in HBSS and preincubated with 1 mM Mn2 ,
20 ng/ml PMA, or a combination of both for 10 min at 37 C. Subse-
quently, cells were allowed to adhere for 30 min at 37 C, and nonadherent
cells were removed by inverse centrifugation for 10 min at 50 g. Adhesion
assays were quantified by fluorimetry using a Biolumin 960 (Molecular Dy-
namics). For all experiments, nonspecific adhesion to Fc 1 fragments wasJEM VOL. 201, June 20, 2005 1997
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subtracted from adhesion to ICAM-1(D1-2)-Fc or VCAM-1-Fc to calcu-
late the fraction of cells adhering specifically to integrin ligands.
To stimulate T cell adhesion through the antigen receptor pathway,
lymph node T cells were stimulated with PMA (10 ng/ml) and ionomycin
(1  g/ml) for 2 d. After washing to remove PMA and ionomycin, T cells
were maintained in IL-2 (20 ng/ml) for 2 d. T cell adhesion was stimulated
by addition of CD3 antibodies (2  g/ml) for the indicated time periods.
Adhesion assays with bEnd.5 endothelial cells were performed using
16-well glass chamber slides (Nunc). Chamber slides were coated with 2.5
 g/well fibronectin (Roche Diagnostics) and cultured with endothelial cells
(2   105/well) for 2 d. Depending on the experiment, endothelial cells
were incubated with 5 nM TNF per well for the last 16 h of culture. After
removal of the cytokine, endothelial cells were coincubated with 5   105
lymphocytes in 100  l adhesion medium (DMEM containing 5% FCS and
25 mM Hepes) for 30 min on a rocking platform. Assays were washed twice
in PBS and fixed in 2.5% glutaraldehyde in PBS at 4 C for 2 h. Bound cells
per predefined field were determined by counting five fields per well. As-
says were performed in triplicates for each value.
Videomicroscopy. Concanavalin A (2.5  g/ml, 16 h; Sigma-Aldrich)–
activated splenic T cells were isolated on a Nycomed gradient and cultured
for 24 h in 20 ng/ml rIL-2/10% FCS/RPMI 1640 before use. For videomi-
croscopy, 35-mm glass bottom microwell dishes (MatTek Corp) were
coated overnight with 50  g/ml murine ICAM-1-Fc, then blocked with
2% BSA in PBS. T cells (4   105/ml in HBSS buffer plus 6 mM MgCl2)
were added and allowed to settle for 10 min at 37 C; nonattached cells were
removed by gentle washing. Images were taken using a Nikon Diaphot 300
microscope, 40  lens, and AQM2001 Kinetic Acquisition Manager software
(Kinetic Imaging Ltd.). Cells were tracked at 5-s intervals using Motion
Analysis software (Kinetic Imaging Ltd.) and the data were analyzed using a
Mathematica notebook (Wolfram Research Inc.) developed by Daniel
Zicha (Cancer Research UK, London. England, UK). Migration speeds
were expressed as mean velocity over 10 min   SEM. Statistical analysis
was performed using the ANOVA test.
Endothelial transmigration assay. Endothelial transmigration assays
were performed as described previously (42) using 6.5-mm transwells
(Corning) with 5  m pore size. Inserts were coated with 50  g/ml laminin
(Roche Diagnostics). bEnd5 endothelioma cells (5   104) were seeded on
the top of each porous filter and cultured for 2 d. Depending on the exper-
iment, the cells were stimulated with 5 nM TNF per well for the last 16 h
of culture. On day 3, 106 lymphocytes were added on the top of each filter
and the assays were run for 4 h at 37 C and 7% CO2. Migrated lymphocytes
were collected for cell counting using CASY (Schärfe System). Confluency
of the endothelial monolayer was confirmed by Giemsa staining of inserts.
Assays were performed as triplicates for each value.
Lymphocyte proliferation and allogeneic mixed lymphocyte reac-
tion. Splenocytes were incubated at 2   105 cells per well in 96-well
round-bottom plates with soluble SEB in 200  l media. Alternatively, B cell–
depleted splenocytes were incubated in wells that were coated with anti-CD3
antibody. To measure cell proliferation, 1  Ci [3H]-thymidine (Amersham
Biosciences) was added after 48 h of culture and incubated for 16 h.
For induction of mixed lymphocyte reactions, allogeneic splenocytes
(H-2d) were used as stimulator cells and cocultured with responder cells at
concentrations of 4   106 cells/ml. The stimulator population was irradi-
ated with 30 Gy before coculture. Proliferation was measured after 88 h by
addition of 1  Ci/well 3[H]-thymidine (Amersham Biosciences) during the
last 16 h of culture.
Cytotoxic lymphocyte assay. Mice were immunized s.c. into the hind
footpad with ovalbumin (150  g/footpad; OVA grade IV, Sigma-Aldrich)
using CpG-DNA 1668 (5 nmol/footpad) as an adjuvant. Draining lymph
nodes were removed 4 d later and cells were cultured for an additional 4 d
in medium supplemented with 10 U/ml rIL-2, which allows expansion of
in vivo primed CTL precursors. 51Cr-release assays were performed with
EL4 target cells pulsed with 0.1  M of the OVA-derived peptide, SIIN-
FEKL. Serial dilutions of effector CTL were added to target cells and 51Cr-
release was measured after 4 h of coculture. Specific lysis was calculated
according to the formula: %specific lysis   [cpm (sample)   cpm (sponta-
neous release)/cpm (maximal release)   cpm (spontaneous release)]   100.
For control, unpulsed EL4 cells were used as targets. Specific lysis of un-
pulsed EL4 cells was  2% in all experiments.
Ex vivo tetramer staining of CD8 T cells. To investigate generation
of cytotoxic T cells, mice were immunized with OVA and CpG-DNA
1668 as described above. 9 d later, draining lymph nodes were analyzed for
presence of SIINFEKL tetramer binding, and thus, peptide-specific CD8-
positive, CD62L low T cells as described (43). In brief, cells were stained
with anti-CD8 APC (clone CD8 ; Caltag), anti-CD62L FITC (clone
MEL-14), and MHC SIINFEKL tetramer PE (H-2Kb/SIINFEKL [257–
264/murine  2-microglobulin streptavidin-PE]) for 1 h at 4 C. Addition-
ally, an Fc block (CD16/CD32, 2.4G2; BD Biosciences) was used to avoid
unspecific antibody binding. For life/death cell discrimination, cells were
incubated with ethidium monoazide bromid (Molecular Probes).
Thioglycollate-induced peritonitis. Mice were injected i.p. with 0.8
ml thioglycollate (Difco Labs; 40.5 mg/ml). After 0 h, 6 h, and 12 h, perito-
neal lavage cells were collected and neutrophils were identified by flow cy-
tometry analysis with Gr-1 and Mac-1 antibodies.
Humoral immune responses. Mice were immunized i.p. with 5  g
TNP-CGG (NP19-CGG) adsorbed to alum. Sera were collected before and
21 d after immunization. Total NP-specific immunoglobulin isotypes (IgM,
IgG1, and IgG2a) were detected using an ELISA with NP17-BSA–conju-
gated plates (10  g/ml in carbonate-buffer, pH 9.5). Sera were diluted
1:500. Murine NP-specific antibodies were detected with alkaline phos-
phatase–conjugated isotype-specific detection antibodies that were obtained
from BD Biosciences (anti-IgG1, anti-IgG2a) or Jackson ImmunoResearch
Laboratories (anti-IgM).
Online supplemental materials. Activated wild-type (Video 1) or LFA-
1d/d (Video 2) splenic T cells were plated on immobilized ICAM-1-Fc (50
 g/ml) in the presence of 6 mM Mg2 . A phase image was taken every 10 s.
Thus, 1 s of film equals 1 min real time. Images were taken with a 40 
lens and AQM2001 Kinetic Acquisition Manager software (Kinetic Imaging
Ltd.). Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20041850/DC1.
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